A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Vasopressin Injection USP, Multiple Dose Vials: Recall – Sub-Potency. According to the Food & Drug Administration FDA’s MedWatch:
American Regent, Inc. is conducting a nationwide voluntary recall of multiple lots of Vasopressin Injection, USP to the Retail/Hospital level. This product recall was initiated by American Regent, Inc. because some vials may not maintain potency throughout their shelf-life. Potential adverse events after administration of solutions that are below potency limits may include reduced effectiveness.
For more information on the American Regent Vasopressin Injection USP recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Vasopressin Injection USP, Multiple Dose Vials: Recall – Sub-Potency.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the American Regent Vasopressin Injection USP recall or safety alert, share your drug or medical device recall or safety alert comments below.